Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

Food and Chemical Toxicology

Volumn 47, Issue 6, 2009, Pages 1362-1367

  Rocha, K K R ^a   Souza, G A ^a   Ebaid, G X ^a   Seiva, F R F ^a   Cataneo, A C ^a   Novelli, E L B ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

High fat diet; Liver; Oxidative stress; Oxidized LDL; Resveratrol

Indexed keywords

DRINKING WATER; GLUCOSE; GLUTATHIONE; LIPID; LIPID HYDROPEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DYSLIPIDEMIA; FEEDING; HYPERGLYCEMIA; LIPID DIET; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RISK FACTOR; WINE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; GLUTATHIONE; LIPID PEROXIDES; LIPIDS; LIPOPROTEINS, LDL; LIVER; MALE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RISK FACTORS; STILBENES; TRIGLYCERIDES; WINE;

RATTUS; RATTUS NORVEGICUS;

EID: 67349286501     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.03.010     Document Type: Article

References (56)

1. Aebi H. Methods of Enzymatic Analysis. second ed. (1974), Verlag Chemie Weinheim, New York
2. Bandele O.J., Clawson S.J., and Osheroff N. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem. Res. Toxicol. 21 (2008) 1-8
3. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kaira A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Couteur D., Sham R.J., Navas P., Puigserver P., Ingram D.K., Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
4. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discovery 5 (2006) 493-506
5. Benguendouz L., Frémont L., and Gozzzelino M.T. Interaction of trans-resveratrol with plasma lipoproteins. Biochem. Pharmacol. 35 (1998) 811-816
6. Bertelli A.A., Giovannini L., Stradi R., Urien S., Tillement J.P., and Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp. Clin. Res. 24 (1998) 51-55
7. Burkitt M.J., and Duncan J. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. Arch. Biochem. Biophys. 381 (2000) 253-263
8. Crowell J.A., Korytko P.J., Morrissey R.L., Booth T.D., and Levine B.S. Resveratrol-associated renal toxicity. Toxicol. Sci. 82 (2004) 614-619
9. Diniz Y.S., Burneiko R.C., Seiva F.R.F., Almeida F.Q., Galhardi C.M., Novelli Filho J.L.V.B., Mani F., and Novelli E.L.B. Diet compounds, glycemic index and obesity-related cardiac effects. Int. J. Cardiol. 124 (2008) 92-99
10. Diniz Y.S., Cicogna A.C., Padovani C.R., Santana L.S., Faine L.A., and Novelli E.L.B. Diets rich in saturated and polyunsaturated fatty acids: metabolic shifting and cardiac health. Nutrition 20 (2004) 230-234
11. Diniz Y.S., Faine L., Galhardi C.M., Rodrigues H.G., Ebaid G.M.X., Burneiko R.C., Cicogna A.C., and Novelli E.L.B. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition 21 (2005) 749-755
12. Diniz Y.S., Rocha K.K.H., Souza G.A., Galhardi C.M., Ebaid G.M.X., Rodrigues H.G., Novelli Filho J.L.V.B., Cicogna A.C., and Novelli E.L.B. Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur. J. Pharmacol. 543 (2006) 151-157
13. Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mut. Res. 523 (2003) 145-150
14. Ebaid G.M.X., Faine L., Diniz Y.S., Rodrigues H.G., Galhardi C.M., Ribas B., Fernandes A.A., and Novelli E.L.B. Effects of digitonin on hyperglycaemia and dyslipidemia induced by high-sucrose intake. Food Chem. Toxicol. 44 (2006) 293-299
15. Ewing J.F., and Janero D.R. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal. Biochem. 232 (1995) 243-248
16. Faine L.A., Diniz Y.S., Almeida J.A., and Novelli E.L.B. Toxicity of ad libitum overfeeding: effects on cardiac tissue. Food Chem. Toxicol. 3 (2002) 130-137
17. Faine L.A., Rodrigues H.G., Galhardi C.M., Ebaid G.M.X., Diniz Y.S., Fernandes A.A.H., and Novelli E.L.B. Butyl hydroxytoluene (BHT)-induced oxidative stress: effects on serum lipids and cardiac energy metabolism in rats. Exp. Toxicol. Pathol. 57 (2006) 221-226
18. Faine L.A., Rodrigues H.G., Galhardi C.M., Ebaid G.M.X., Diniz Y.S., and Novelli E.L.B. Effects of olive oil and its minor constituents on serum lipids, oxidative stress, and energy metabolism in cardiac muscle. Can. J. Physiol. Pharmacol. 84 (2006) 239-245
19. Ferreira M.P., and Willoughby D. Alcohol consumption: the good, the bad, and the indifferent. Appl. Physiol. Nutr. Metab. 33 (2008) 12-20
20. Frémont L. Biological effects of resveratrol. Life Sci. 66 (2000) 663-673
21. Frémont L., Belguendouz L., and Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenol related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64 (1999) 2511-2521
22. Friedewald W.T., Levy R., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
23. Fukuhara K., and Miyata N. Resveratrol as a new type of DNA-cleaving agent. Bioorg. Med. Chem. Lett. 8 (1998) 3187-3192
24. Heinecke J.W. Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?. J. Exp. Med. 203 (2006) 813-816
25. Jannin B., Menzel M., Berlot J., Delmas D., Lançon A., and latruffe N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmic protein binding and cell uptake. Biochem. Pharmacol. 68 (2004) 1113-1118
26. 3+ in the presence of xylenol orange. Lipids 26 (1991) 853-856
27. Juan M.E., Buenafuente J., Casals I., and Planas J.M. Plasmatic levels of trans-resveratrol in rats. Food Res. Int. 35 (2002) 195-199
28. Kuhnle G., Spencer J.P.E., Chowrimootoo G., Schroeter H., Debnam E.S., Srai K.S., Rice-Evans C., and Hahn U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun. 272 (2000) 212-217
29. Lançon A., Delmas D., Osman H., Thénot J.P., Jannin B., and Latruffe N. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316 (2004) 1132-1137
30. Lowry D.H., Rosebrough N.J., and Farr A.L. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
31. Milde J., Elstner E.F., and Grabmann J. Synergistic effects of polyphenols and carotenoids on human low-density lipoprotein oxidation. Mol. Nutr. Food Res. 51 (2007) 956-961
32. Miller A., and Blakely W. Inhibition of glutathione reductase activity by a carbamoylating nitrosurea. Free Rad. Biol. Med. 2 (1992) 53-62
33. Moriarty-Craige S.E., and Jones D.P. Extracellular thiols and thiol/disulfide redox metabolism. Ann. Rev. Nutr. 24 1 (2004) 481-509
34. Nakamura W., Hosoda S., and Hayashi K. Purification and properties of rat liver glutathione preoxidase. Biochim. Biophys. Acta 358 (1974) 251-261
35. Niki E., Yoshida Y., Saito Y., and Noguchi N. Lipid peroxidation: mechanisms, inhibition and biological effects. Biochem. Biophys. Res. Commun. 338 (2005) 668-676
36. Novelli E.L.B. Nutrição e vida saudável. Estresse Oxidativo e Metabolismo Energético (2005), Tecmedd Editora, São Paulo
37. Novelli E.L.B., Diniz Y.S., Galhardi C.M., Ebaid G.M.X., Rodrigues H.G., Mani F., Fernandes A.A.H., Cicogna A.C., and Novelli Filho J.L.V.B. Anthropometrical parameters and markers of obesity in rats. Lab. Animal 41 (2007) 111-119
38. Oak M.H., Bedour J.E., and Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 16 (2005) 1-8
39. Ou H.C., Chou F.P., Sheen H.M., Lin T.M., Yang C.H., and Sheu W.H.H. Resveratrol, a polyphenol compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin. Chim. Acta 364 (2006) 196-204
40. Park C.E., Kim M.J., Lee J.H., Min B., Bae H., Choe W., Kim S.S., and Ha J. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 39 (2007) 222-229
41. Ray P.S., Maulik G., Cordis G.A., Bertelli A., and Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts fro ischemia reperfusion injury. Free Rad. Biol. Med. 27 (1999) 160-169
42. Reeves P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 127 (1997) 838-841
43. Rivabene R., Napolitano M., Cantafora A., and Bravo E. Redox-dependent modulation of lipid synthesis induced by oleic acid in the human intestinal epithelial cell line caco-2. Exp. Biol. Med. 226 (2001) 191-198
44. Rodrigues H.G., Diniz Y.S., Faine L., Galhardi C.M., Burneiko R., Almeida J., Ribas B., and Novelli E.L.B. Antioxidant effect of saponin: potential action of a soybean flavonoid on glucose tolerance and risk factors for atherosclerosis. Int. J. Food Sci. Nutr. 56 (2005) 79-85
45. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 130 (2000) 2073-2085
46. Schaffer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Rad. Biol. Med. 36 (2001) 1191-1212
47. Schaffer J.E. Lipotoxicity: when tissues overeat. Cur. Opin. Lipidol. 14 (2003) 281-287
48. Scoccia A.E., Molinuevo M.S., McCarthy A.D., and Cortizo A. A simple method to assess the oxidative susceptibility of low-density lipoproteins. Clin. Pathol. 1 (2001) 1-12
49. Seve M., Chimienti F., Devergnas S., Aouffen M., Douki T., Chantegrel J., Cadet J., and Favier A. Resveratrol enhances UVA-induced DNA damage in HaCat human keratinocytes. Med. Chem. 1 (2005) 629-633
50. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., and Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 111 (1999) 1050-1055
51. Stojanovic S., Sprinz H., and Brede O. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch. Biochem. Biophys. 391 (2001) 79-89
52. Szkudelski T. Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur. J. Pharmacol. 552 (2006) 176-181
53. Tietze F. Enzyme method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27 (1969) 502-522
54. Wang Z., Zou J., Cao K., Hsieh T.C., Huang Y., and Wu J.M. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 16 (2005) 533-540
55. Wilson T., Knight T.J., Beitz D.C., Lewis D.S., and Engen R.J. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sci. 59 (1996) 15-21
56. Zou J., Huang Y., and Cao K. Effects of resveratrol on oxidative modification of human low-density lipoprotein. Chin. Med. J. 113 (2000) 99-102